A UK-based multinational pharmaceutical company approached Freyr to update the PLLR for their generic products. The client had to perform literature review and prepare the literature summary report for applicable PLLR section of the USPI. As the generic was an old, regulated molecule since 1952 and had vast data availability, it was challenging to identify the crucial information form the available voluminous literature.

How did Freyr manage to provide expedited services for the submission of first-time ready documents in a timely manner? Discover with this proven case. Download.